SGMT 8-K: SEC filing
Sagimet Biosciences
Filed with the SEC on · accession 0001193125-26-457000
SGMT filed a 8-K (current report) with the SEC on Nov 12, 2026. Sagimet Biosciences issued a press release announcing its financial results for the quarter ended September 30, 2026, and updated its investor presentation. The stock moved -3.5% by the first close after the filing.
Summary of the filing
Sagimet Biosciences issued a press release announcing its financial results for the quarter ended September 30, 2026, and updated its investor presentation. The filing is a routine earnings and Regulation FD disclosure.
Key details
How SGMT stock reacted
Close before
$11.41
Nov 11, 2026
First close after
-3.46%
$11.02
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for SGMT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SGMT?
Click hereFrequently asked questions
What did SGMT file with the SEC on Nov 12, 2026?
SGMT filed a 8-K (SEC filing). Sagimet Biosciences issued a press release announcing its financial results for the quarter ended September 30, 2026, and updated its investor presentation. The filing is a routine earnings and Regulation FD disclosure.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did SGMT stock react to this filing?
SGMT closed at $11.41 before the filing and $11.02 on Nov 12, 2026 (-3.46%).
Other SGMT SEC filings
- 10-Q · SEC filingNov 12, 2026
- 8-K · SEC filingOct 22, 2026
- SCHEDULE 13G · SEC filingOct 7, 2026
- 8-K · Secondary offeringOct 1, 2026
- 424B3 · Secondary offeringSep 30, 2026
- 8-K · Fda approvalSep 30, 2026
- SCHEDULE 13G · SEC filingAug 14, 2026
- 8-K · Fda approvalAug 13, 2026
- 8-K · SEC filingAug 11, 2026
- 10-Q · SEC filingAug 11, 2026
Get alerts when SGMT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days